|Source:||The aerial parts of Artemisia hispanica.|
|Solvent:||Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||2.6713 mL||13.3565 mL||26.713 mL||53.4259 mL||66.7824 mL|
|5 mM||0.5343 mL||2.6713 mL||5.3426 mL||10.6852 mL||13.3565 mL|
|10 mM||0.2671 mL||1.3356 mL||2.6713 mL||5.3426 mL||6.6782 mL|
|50 mM||0.0534 mL||0.2671 mL||0.5343 mL||1.0685 mL||1.3356 mL|
|100 mM||0.0267 mL||0.1336 mL||0.2671 mL||0.5343 mL||0.6678 mL|
Biomed Res Int. 2017;2017:7375615.
|Inhibitory Effect of Chemical Constituents Isolated from Artemisia iwayomogi on Polyol Pathway and Simultaneous Quantification of Major Bioactive Compounds.[Pubmed: 28512639 ]|
|Blocking the polyol pathway plays an important role preventing diabetic complications. Therefore, aldose reductase (AR) and advanced glycation endproducts (AGEs) formation has significant effect on diabetic complications. Artemisia iwayomogi has long been used as treatment of various diseases in Korea. However, no literatures have reported on AR and AGEs formation inhibitory activities of A. iwayomogi. For these reasons, we aimed to assess that A. iwayomogi had potential as anti-diabetic complications agents. We led to isolation of two coumarins (1 and 2), nine flavonoids (3-11), five caffeoylquinic acids (12-16), three diterpene glycosides (17-19), and one phenolic compound (20) from A. iwayomogi. Among them, hispidulin (4), 6-methoxytricin (6), Arteanoflavone (7), quercetin-3-gentiobioside (10), 1,3-di-O-caffeoylquinic acid (13), and suavioside A (18) were first reported on the isolation from A. iwayomogi. Not only two coumarins (1 and 2), nine flavonoids (3-11), and five caffeoylquinic acids (12-16) but also extracts showed significant inhibitor on AR and AGEs formation activities. We analyzed contents of major bioactive compounds in Korea's various regions of A. iwayomogi. Overall, we selected Yangyang, Gangwon-do, from June, which contained the highest amounts of bioactive compounds, as suitable areas for cultivating A. iwayomogi as preventive or therapeutic agent in the treatment of diabetic complications.|
Phytochemistry, 1988, 27(10):3155-3159.
|Flavonoids and other phenolics from Artemisia hispanica.[Reference: WebLink]|
|Extraction of aerial parts of Artemisia hispanica and chromatographic separation yielded chrysosplenetin, chrysosplenol D, 5,7,3′,4′-tetrahydroxy-6,5′-dimethoxyflavone, 5,7,3′-trihydroxy-6,4′,5′-trimethoxyflavone, Arteanoflavone, cirsilineol, penduletin, axillarin, jaceosidin, apigenin, luteolin, p-hydroxyacetophenone, 4-(p-hydroxyphenyl) butan-2-one, methyl caffeate, esculetin, apigenin 7-glucoside, luteolin 7-glucoside and the new flavonoids 5,3′,4′-trihydroxy-6,7,5′-trimethoxyflavone and isoetin 5′-glucoside.|